NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ZeroHarm Sciences

ZeroHarm Sciences

Private
HyderabadHealthcare & Life Scienceshttps://www.zeroharm.in/

Last Round

Series A

Feb 25, 2026

Total Funding Raised

$7.15M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ZeroHarm Sciences is a nutraceutical company that develops plant-based health supplements using proprietary nano-formulation technology.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Biotechnology, Sports & Fitness, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

nutraceuticalsplant-based supplementsbioavailabilitynano-formulationD2Cdirect-to-consumerhealth supplementspreventive careintegrative carewellness brandclean labelbiohackingquick commercesupplement stackGMP-certified

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZeroHarm Sciences Comparables

Compare ZeroHarm Sciences with similar companies based on industry and business-model similarity.

ZeroHarm Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hindustan Unilever
83%
USV Private Limited
81%
Cymbiotika
79%

ZeroHarm Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 25, 2026

Key People

Founding team and executive leadership

Ganesh P.

Chief Operating Officer

Executive Team

ZeroHarm Sciences Investors

Notable investors and investment history

ZeroHarm Sciences investors
InvestorRounds
Alkemi Growth CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    $7.15M round led by Kotak Lifesciences Fund I.

  • Jan 2, 2026

    Monthly visitors increased 110% MoM, reaching 95.3K.

ZeroHarm Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ZeroHarm Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZeroHarm Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersHyderabad
Employee Range48
Year Founded2020
Last FundingFeb 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.